Pravin Dugel

CIK: 0001700917

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)9 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (11.1%)

Compensation grants

Other (G, F, J, C, D, …)15 (55.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OCUL

OCULAR THERAPEUTIX, INC

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (27 total)

OCUL
OCULAR THERAPEUTIX, INC
Aug 25, 2026
Gift(G)
Indirect
50.1K shares-
OCUL
OCULAR THERAPEUTIX, INC
Aug 25, 2026
Gift(G)
Indirect
50.1K shares-
OCUL
OCULAR THERAPEUTIX, INC
Aug 24, 2026
Sale(S)
Direct
21.6K shares at avg. $10.77$233K
OCUL
OCULAR THERAPEUTIX, INC
Jun 16, 2026
Gift(G)
Direct
50.1K shares-
OCUL
OCULAR THERAPEUTIX, INC
Jun 16, 2026
Gift(G)
Indirect
50.1K shares-
OCUL
OCULAR THERAPEUTIX, INC
May 28, 2026
Gift(G)
Indirect
394.7K shares-
OCUL
OCULAR THERAPEUTIX, INC
May 28, 2026
Gift(G)
Indirect
394.7K shares-
OCUL
OCULAR THERAPEUTIX, INC
May 26, 2026
Sale(S)
Direct
21.2K shares at avg. $8.20$173K
OCUL
OCULAR THERAPEUTIX, INC
Apr 9, 2026
Gift(G)
Indirect
394.7K shares-
OCUL
OCULAR THERAPEUTIX, INC
Apr 9, 2026
Gift(G)
Direct
394.7K shares-
OCUL
OCULAR THERAPEUTIX, INC
Feb 23, 2026
Sale(S)
Direct
20.1K shares at avg. $8.28$166K
OCUL
OCULAR THERAPEUTIX, INC
Feb 12, 2026
Sale(S)
Direct
124.9K shares at avg. $9.04$1.1M
OCUL
OCULAR THERAPEUTIX, INC
Nov 26, 2025
Gift(G)
Indirect
49.8K shares-
OCUL
OCULAR THERAPEUTIX, INC
Nov 26, 2025
Gift(G)
Indirect
49.8K shares-
OCUL
OCULAR THERAPEUTIX, INC
Nov 24, 2025
Sale(S)
Direct
19.5K shares at avg. $12.04$235K
OCUL
OCULAR THERAPEUTIX, INC
Sep 9, 2025
Gift(G)
Indirect
49.8K shares-
OCUL
OCULAR THERAPEUTIX, INC
Sep 9, 2025
Gift(G)
Direct
49.8K shares-
OCUL
OCULAR THERAPEUTIX, INC
Aug 25, 2025
Sale(S)
Direct
21.5K shares at avg. $12.04$259K
OCUL
OCULAR THERAPEUTIX, INC
Aug 11, 2025
Gift(G)
Indirect
250.4K shares-
OCUL
OCULAR THERAPEUTIX, INC
Jun 12, 2025
Gift(G)
Direct
50K shares-
OCUL
OCULAR THERAPEUTIX, INC
Jun 11, 2025
Award(A)
Performance Stock Option (Right to Buy)
Direct
2.8M shares-
OCUL
OCULAR THERAPEUTIX, INC
May 23, 2025
Sale(S)
Direct
21.2K shares at avg. $7.18$152K
OCUL
OCULAR THERAPEUTIX, INC
Apr 28, 2025
Gift(G)
Direct
200.3K shares-
OCUL
OCULAR THERAPEUTIX, INC
Feb 24, 2025
Sale(S)
Direct
21.5K shares at avg. $6.87$148K
OCUL
OCULAR THERAPEUTIX, INC
Feb 11, 2025
Award(A)
Direct
1.5M shares-

		Type	Shares	Price		Ownership
Aug 25, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	50,092	-	$0	Indirect
Aug 25, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	50,092	-	$0	Indirect
Aug 24, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	21,649	$10.77	$233,160	Direct
Jun 16, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	50,092	-	$0	Direct
Jun 16, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	50,092	-	$0	Indirect
May 28, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	394,696	-	$0	Indirect
May 28, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	394,696	-	$0	Indirect
May 26, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	21,156	$8.20	$173,479	Direct
Apr 9, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	394,696	-	$0	Indirect
Apr 9, 2026	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	394,696	-	$0	Direct
Feb 23, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	20,056	$8.28	$166,064	Direct
Feb 12, 2026	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	124,882	$9.04	$1,128,933	Direct
Nov 26, 2025	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	49,754	-	-	Indirect
Nov 26, 2025	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	49,754	-	-	Indirect
Nov 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	19,530	$12.04	$235,141	Direct
Sep 9, 2025	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	49,754	-	-	Indirect
Sep 9, 2025	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	49,754	-	-	Direct
Aug 25, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	21,494	$12.04	$258,788	Direct
Aug 11, 2025	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	250,361	-	-	Indirect
Jun 12, 2025	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	50,029	-	-	Direct
Jun 11, 2025	OCUL OCULAR THERAPEUTIX, INC	Award(A) Performance Stock Option (Right to Buy)	2,750,000	-	-	Direct
May 23, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	21,219	$7.18	$152,352	Direct
Apr 28, 2025	OCUL OCULAR THERAPEUTIX, INC	Gift(G)	200,332	-	-	Direct
Feb 24, 2025	OCUL OCULAR THERAPEUTIX, INC	Sale(S)	21,475	$6.87	$147,533	Direct
Feb 11, 2025	OCUL OCULAR THERAPEUTIX, INC	Award(A)	1,500,000	-	-	Direct

1-25 of 27 transactions

About Dugel Pravin

Dugel Pravin (SEC CIK 0001700917) files insider reports with the SEC as Director of OCULAR THERAPEUTIX, INC (OCUL).

Signal8 holds 15 ownership filings by Dugel Pravin, all Form 4s, filed between Nov 27, 2024 and Aug 26, 2026. Those filings report 27 transactions, from Nov 25, 2024 to Aug 25, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dugel Pravin's filings is in BEDFORD, MA.

Recent filings by Dugel Pravin

Aug 25, 2026: Gifts of OCUL shares (2 lines, Form 4, code G).
Aug 24, 2026: Open-market sale of OCUL shares (Form 4, code S).
Jun 16, 2026: Gifts of OCUL shares (2 lines, Form 4, code G).
May 28, 2026: Gifts of OCUL shares (2 lines, Form 4, code G).
May 26, 2026: Open-market sale of OCUL shares (Form 4, code S).

Other insiders filing for OCULAR THERAPEUTIX, INC (OCUL)

Anderman Todd, Chief Legal Officer
Kaiser Peter, Chief Development Officer
Heier Jeffrey S., Chief Scientific Officer
Notman Donald, Chief Operating Officer
Nayak Sanjay, Chief Strategy Officer
Warden Charles M, Director

How to read Form 4 transaction codes